B2M and focal segmental glomerulosclerosis: Signal with m/z 2713.96, identified as a fragment of beta-2-microglobulin (B2M; Swiss-Prot accession No.: P61769; Homo sapiens; the amino acid sequence matched was 59–81) [12], showed a higher peak area in healthy subjects compared with MCD and FSGS patients.